• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[神奇子弹、化学压制、可控风险?关于德国研究基金会(DFG)“20世纪的药物”网络研究]

[Magic bullets, chemical gagging, controlled risks? On the research of the network "Pharmaceuticals in the 20th century" of the German Research Foundation (DFG)].

作者信息

Balz Viola, Bürgi Michael, Eschenbruch Nicholas, Hulverscheidt Marion

机构信息

Institüt für Ethik und Geschichte der Medizin, albert-Ludwigs-Universität Freiburg, Freiburg, Deutschland.

出版信息

Medizinhist J. 2008;43(2):183-201.

PMID:18839933
Abstract

Therapeutic substances, their development, testing, application and effects, have in recent years become a central topic of the history of medicine, history of science, and science and technology studies. This paper provides an overview of the literature on this topic through the four-fold perspective of individual substances, industry, patients, and regulation. It introduces the recently established, DFG-funded research network "Pharmaceuticals in the 20th Century" and sketches current methodological approaches to the history of therapeutic substances. At present it appears to be particularly promising to adopt an approach which uses substances or groups of substances as a heuristic device for exploring their complex networks and interdependencies.

摘要

近年来,治疗性物质及其研发、测试、应用和效果已成为医学史、科学史以及科学技术研究领域的核心话题。本文通过个体物质、产业、患者和监管这四个视角,对该主题的文献进行了综述。它介绍了最近由德国研究基金会资助成立的研究网络“20世纪的药物”,并概述了当前治疗性物质史的方法论。目前,采用一种将物质或物质组作为探索其复杂网络和相互依存关系的启发式工具的方法似乎特别有前景。

相似文献

1
[Magic bullets, chemical gagging, controlled risks? On the research of the network "Pharmaceuticals in the 20th century" of the German Research Foundation (DFG)].[神奇子弹、化学压制、可控风险?关于德国研究基金会(DFG)“20世纪的药物”网络研究]
Medizinhist J. 2008;43(2):183-201.
2
[Psychochemicals crossing the wall. The introduction of psychoactive pharmaceuticals in the German Democratic Republic--a perspective from the new historiography of drugs].[穿越壁垒的精神化学物质。民主德国精神活性药物的引入——来自毒品新史学的视角]
Medizinhist J. 2007;42(1):61-84.
3
[The industrialisation of therapeutic agents: a story of practices between science, technology, medicine and the law].[治疗药物的产业化:科学、技术、医学与法律之间的实践故事]
Gesnerus. 2007;64(1-2):93-108.
4
Drug development history, "overview," and what are GCPs?药物研发历史、“概述”以及什么是药物临床试验规范?
Qual Assur. 1995 Mar;4(1):75-9.
5
[30 years in the history of drugs and drug therapy].[药物与药物治疗史三十年]
Cah Sociol Demogr Med. 1994 Oct-Dec;34(4):325-52.
6
The history and contemporary challenges of the US Food and Drug Administration.美国食品药品监督管理局的历史与当代挑战
Clin Ther. 2007 Jan;29(1):1-16. doi: 10.1016/j.clinthera.2007.01.006.
7
The evolution of human medicines control from a national to an international perspective.人类药品监管从国家层面到国际层面的演变。
Adverse Drug React Toxicol Rev. 1998 Mar;17(1):19-50.
8
The right to a trial: Should dying patients have access to experimental drugs?审判权:临终患者是否应有权使用实验性药物?
New Yorker. 2006 Dec 18:40-7.
9
[Early achievements of the Danish pharmaceutical industry--2. The minor and almost forgotten pharmaceutical companies].[丹麦制药行业的早期成就——2. 规模较小且几乎被遗忘的制药公司]
Theriaca. 2009(38):7-71.
10
History and philosophy of Bayer pharmaceutical research.
Arzneimittelforschung. 1989 Aug;39(8A):935-7.

引用本文的文献

1
[The introduction of antipsychotics in the neurological psychiatric hospital of the University of Leipzig and their effects on other forms of therapy, the length of stay and transferrals].[莱比锡大学神经精神病医院抗精神病药物的引入及其对其他治疗形式、住院时间和转院的影响]
Nervenarzt. 2021 Jan;92(1):69-80. doi: 10.1007/s00115-020-00931-y.